India MCA Corporate Compliance Enforcement — May 15, 2026

India MCA Compliance & Enforcement

By Gunpowder Editorial ·

8 high priority 8 total filings analysed

Executive Summary

Across the 8 filings in the India MCA Compliance & Enforcement stream, dominant themes include mixed financial performance in the chemicals sector led by Fineotex Chemical's strong consolidated growth (Q4 revenue +161.91% YoY to ₹313.73 Cr, FY +44.79% to ₹772.23 Cr, PAT +117.56% Q4) contrasting sharp standalone declines (-9.6% YoY FY revenue), alongside minor regulatory penalties and compliance issues in infrastructure, engineering, and trading firms with negligible materiality.

Period-over-period trends highlight robust consolidated volume surges (e.g., Fineotex +131% YoY Q4) but persistent standalone revenue contractions and negative operating cash flow (-₹7,310.92 Lakhs FY), signaling reliance on subsidiaries or group entities. Capital allocation remains shareholder-friendly with Fineotex's FY dividend payout rising 63% YoY to ₹14.98 Cr and Camlin Fine Sciences achieving 100% utilization of ₹224.68 Cr rights issue proceeds primarily for debt repayment (₹169 Cr). No insider trading activity reported across filings, reducing conviction signals, while forward-looking catalysts include Godavari Biorefineries' earnings call on May 26, 2026. Portfolio-level patterns show 3/8 filings with high materiality (all Fineotex variants), low-impact fines in 3/8 (Noida Toll, Isgec, Dolat), and neutral/positive sentiment in growth stories vs. negative in compliance slips, implying selective opportunities in outperforming chemical consolidates amid broad regulatory noise.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior India MCA Corporate Compliance Enforcement digest from May 14, 2026.

Investment Signals (10)

  • Consolidated Q4 revenue +161.91% YoY to ₹313.73 Cr, PAT +117.56% to ₹43.80 Cr, EBITDA +85.87% to ₹53.15 Cr, volumes +131% YoY

  • FY consolidated revenue +44.79% YoY to ₹772.23 Cr, PAT +14.50% to ₹125.01 Cr, ROIC at 31.10% vs prior periods

  • FY dividend payout +63% YoY to ₹14.98 Cr (final ₹0.05/share), total from ₹9.16 Cr prior, signaling strong cash confidence

  • 100% utilization of ₹224.68 Cr rights issue proceeds by Mar 31, 2026, with ₹169 Cr to debt repayment (revised up), no deviations

  • Consolidated Q4 volumes +59% QoQ and +131% YoY, standalone assets +17.7% to ₹81,786 Lakhs, Great Place to Work 5th year

  • Rights issue fully deployed to corporate purposes (₹55 Cr revised) and expenses, certified by auditors, 439 shares in abeyance minor

  • Bonus shares 4:1 (91.66 Cr issued Oct 31, 2025) and FV split ₹2 to ₹1, enhancing liquidity post strong FY results

  • Earnings call scheduled May 26, 2026, with CMD participation, potential for FY26 guidance post Q4 results

  • Fineotex Chemical (NEUTRAL-BULLISH)

    Standalone Q4 revenue flat QoQ at ~₹9,760 Lakhs vs Q3 ₹9,647 Lakhs, stabilizing after FY decline

  • Promoters (Ashish/Anagha Dandekar holdings) backed rights issue at ₹110/share (FV ₹1), full deployment positive conviction

Risk Flags (7)

Opportunities (8)

Sector Themes (5)

  • Chemicals Mixed Divergence

    4/8 filings (Fineotex x3, Camlin, Godavari) show cons/group growth (avg +80% YoY Q4 rev) vs stand declines (-9% avg), implies sub-co reliance [IMPLICATION: Favor holding cos]

  • Minor Penalty Proliferation

    3/8 filings (Noida Toll, Isgec, Dolat) with fines <₹38L total (avg ₹15L), all 'no material impact', compliance fatigue in infra/engg/trading [IMPLICATION: Negligible pricing but watch repeats]

  • Capital Return Focus

    Fineotex dividend +63% YoY (₹15 Cr), Camlin 100% rights to debt/capex, no buybacks/splits beyond Fineotex bonus [IMPLICATION: Shareholder friendly amid growth]

  • Low Insider Visibility

    Zero reported insider trades/pledges across 8 filings, neutral conviction vs historical patterns [IMPLICATION: Lack of strong mgmt signals]

  • Catalyst Clustering May 2026

    Godavari call (May 26), penalties received May 14-15, Fineotex results approved, short-term volatility window [IMPLICATION: Trade around events]

Watch List (7)

Filing Analyses (8)
Fineotex Chemical Limited Regulatory Action mixed materiality 9/10

15-05-2026

Fineotex Chemical Limited's Board approved audited standalone and consolidated financial results for Q4 and FY 2025-26, with consolidated revenue surging 161.91% YoY to ₹313.73 Crores in Q4 and 44.79% to ₹772.23 Crores for FY, PAT rising 117.56% to ₹43.80 Crores in Q4 and 14.50% to ₹125.01 Crores for FY, alongside EBITDA up 85.87% to ₹53.15 Crores in Q4. However, standalone revenue declined ~9.6% YoY to ₹39,687.83 Lakh for FY from ₹43,922.21 Lakh and ~9.6% to ₹9,759.98 Lakh in Q4 from ₹10,794.60 Lakh, with PAT down ~5.5% to ₹9,188.96 Lakh for FY from ₹9,722.67 Lakh. The Board recommended a final dividend of Rs. 0.05 per equity share (FV ₹1), totaling FY dividend of Rs. 14,98,85,117 up from Rs. 9,16,60,072 prior year.

  • · Consolidated Q4 volume growth of approximately 59% QoQ and 131% YoY.
  • · Standalone Q3 FY26 revenue ₹9,647.47 Lakh (flat QoQ vs Q4 ₹9,759.98 Lakh).
  • · Company recognized as Great Place to Work® for 5th consecutive year.
  • · Equity share face value split from ₹2 to ₹1, bonus issue 4:1 (91,66,00,720 shares allotted Oct 31, 2025), authorised capital increased to ₹12,000 Lakh.
  • · 23,15,049 warrants lapsed, ₹2,242.12 Lakh forfeited to Capital Reserve.
  • · Standalone ROE implied from equity ₹75,429.50 Lakh and PAT ₹9,188.96 Lakh.
Camlin Fine Sciences Limited Regulatory Action positive materiality 7/10

15-05-2026

Camlin Fine Sciences Limited filed the final Monitoring Agency Report for the quarter ended March 31, 2026, confirming 100% utilization of ₹22,468.39 Lakhs received from the Rights Issue of 2,04,26,244 Equity Shares (₹22,468.87 Lakhs original size), with no deviations from the objects stated in the Letter of Offer. Proceeds were allocated to repayment of borrowings (₹16,904.93 Lakhs revised), general corporate purposes (₹5,494.22 Lakhs revised), and issue-related expenses (₹69.24 Lakhs revised), fully deployed by quarter-end. The report, issued by India Ratings & Research Private Limited and certified by statutory auditors Kalyaniwalla & Mistry LLP, notes 439 shares in abeyance, reducing proceeds by ₹0.48 Lakh.

  • · Issue period: January 17, 2025 to January 27, 2025
  • · Equity Shares: Face value ₹1 each at ₹110 per share
  • · Promoters include Ashish Dandekar, Anagha Dandekar, and several holding companies
  • · No favorable or unfavorable events affecting object viability
  • · All government/statutory approvals obtained; no material deviations or changes in means of finance
  • · GCP breakdown for period: Electricity ₹187.93 L, Salary ₹434.24 L, Vendor Payments ₹199.80 L (total ₹821.97 L during quarter)
Godavari Biorefineries Limited Regulatory Action neutral materiality 4/10

15-05-2026

Godavari Biorefineries Limited has announced an earnings conference call scheduled for Tuesday, May 26, 2026, at 11:00 AM IST, to discuss its Q4 and FY26 financial and operational performance ending March 31, 2026. The call will feature Mr. Samir Somaiya (Chairman & Managing Director) and Mr. Ashish Sinha (AGM, Investor Relations & Finance) as speakers, with dial-in numbers and pre-registration details provided. No unpublished price-sensitive information will be shared during the call.

  • · Script Symbol: GODAVARIB
  • · Script Code: 544279
  • · Universal Dial In: +91 22 6280 1550 / +91 22 7115 8378
  • · International Toll-Free: USA: 1866 746 2133; UK: 0808 101 1573; Singapore: 800 101 2045; Hong Kong: 800 964 448
  • · RSVP Contacts: investorrelations@somaiya.com; prachi.ambre@in.mpms.mufg.com; irfan.raeen@in.mpms.mufg.com
  • · Company Website: https://godavaribiorefineries.com/
Noida Toll Bridge Company Limited Regulatory Action negative materiality 3/10

15-05-2026

Noida Toll Bridge Company Limited was levied a fine of ₹7,080 (inclusive of GST) by the National Stock Exchange of India Limited (NSE) for non-compliance with Regulation 31 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, via a letter dated May 14, 2026. The company disclosed this under Regulation 30 of SEBI LODR and states there is no material impact on its financial, operational, or other activities.

  • · Date of receipt of NSE letter: May 14, 2026
  • · BSE Scrip Code: 532481
  • · NSE Scrip Code: NOIDATOLL
  • · CIN: L45101DL1996PLC315772
Isgec Heavy Engineering Limited Regulatory Action negative materiality 3/10

15-05-2026

ISGEC Heavy Engineering Ltd. received an order from the Assistant Commissioner/GSTO, Ward 62, Zone 5, Delhi, imposing a penalty of Rs.2,20,112/-, interest of Rs.14,83,677/-, and tax demand of Rs.20,70,589/-, totaling Rs.37,74,378/- for alleged excess availment of Input Tax Credit in FY 2022-23. The company plans to file an appeal under the Goods and Services Tax Act. The financial impact is quantifiable at Rs.37,74,378/- with no operational impact mentioned.

  • · Order received on May 15, 2026, at 14:15:00 HRS
  • · Disclosure under Regulation 30 read with Para A of Part A of Schedule III of Listing Regulations
  • · Company GST No.: 09AAACT5540K2Z4
Fineotex Chemical Limited Regulatory Action mixed materiality 9/10

15-05-2026

The Board of Fineotex Chemical Limited approved audited standalone and consolidated financial results for Q4 and FY 2025-26 ending March 31, 2026, with consolidated revenue surging 161.91% YoY to ₹313.73 Crores in Q4 and 44.79% to ₹772.23 Crores for the FY, alongside PAT growth of 117.56% to ₹43.80 Crores and 14.50% to ₹125.01 Crores. However, standalone revenue declined 9.6% YoY to ₹39,687.83 Lakhs for FY from ₹43,922.21 Lakhs and 9.6% in Q4 to ₹9,759.98 Lakhs from ₹10,794.60 Lakhs, with operating cash flow negative at ₹7,310.92 Lakhs. The Board recommended a final dividend of Rs. 0.05 per share (total FY dividend ₹14,98,85,117 vs. prior ₹9,16,60,072).

  • · Consolidated ROIC for FY 2025-26 at 31.10%.
  • · Standalone total assets increased to ₹81,786.39 Lakhs from ₹69,483.85 Lakhs.
  • · Company recognized as Great Place to Work® for 5th consecutive year.
  • · Paid-up equity share capital increased to ₹11,645.01 Lakhs post bonus issue, stock split, and warrant conversions.
  • · Operating cash flow negative primarily due to ₹14,257.17 Lakhs increase in working capital usage.
Fineotex Chemical Limited Regulatory Action mixed materiality 9/10

15-05-2026

Fineotex Chemical Limited's Board approved audited standalone and consolidated financial results for Q4 and FY 2025-26 ending March 31, 2026, with consolidated Q4 revenue surging 161.91% YoY to ₹313.73 Crores and FY revenue growing 44.79% YoY to ₹772.23 Crores, while PAT rose 117.56% to ₹43.80 Crores in Q4 and 14.50% to ₹125.01 Crores for FY. However, standalone FY revenue declined 9.64% YoY to 39,687.83 Lakhs from 43,922.21 Lakhs, PAT fell 5.49% to 9,188.96 Lakhs, and operating cash flow was negative at 7,310.92 Lakhs. The Board recommended a final dividend of ₹0.05 per equity share (FV ₹1), bringing total FY dividend to ₹14,98,85,117, up from ₹9,16,60,072 prior year.

  • · Consolidated ROIC for FY 2025-26 at 31.10%.
  • · Standalone Q4 FY 2025-26 Revenue from Operations: 9,759.98 Lakhs (down YoY from 10,794.60 Lakhs).
  • · Company issued 91,66,00,720 bonus equity shares in 4:1 ratio on October 31, 2025; equity share face value split from ₹2 to ₹1.
  • · 23,15,049 warrants lapsed, forfeiting ₹2,242.12 Lakhs transferred to Capital Reserve.
  • · Authorised share capital increased to ₹12,000 Lakhs.
Dolat Algotech Limited Regulatory Action negative materiality 3/10

15-05-2026

Dolat Algotech Limited disclosed receiving a penalty of ₹1,18,000 from NSE Clearing Limited for TM/FPI Limit Violation, consisting of a basic fine of ₹1,00,000 plus ₹18,000 GST, with the intimation received on May 14, 2026. The company states this penalty has no material impact on its financials, operations, or other activities beyond the monetary amount.

  • · Disclosure made pursuant to Regulation 30 of SEBI Listing Regulations.
  • · Scrip code: 505526 (BSE); Symbol: DOLATALGO (NSE).
  • · Corporate Identity Number: L67100GJ1983PLC126089.

Get daily alerts with 10 investment signals, 7 risk alerts, 8 opportunities and full AI analysis of all 8 filings

₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: India MCA Corporate Compliance Enforcement

🇮🇳 More from India

View all →